Diabetes Care Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: D40F85ADDA05EN
Market Monitor Global

Abstracts

Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially eyes, kidneys, heart, blood vessels and nerves.Diabetes care drugs are used to treat diabetes.

This report contains market size and forecasts of Diabetes Care Drugs in Global, including the following market information:

Global Diabetes Care Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetes Care Drugs market was valued at 67200 million in 2021 and is projected to reach US$ 95620 million by 2028, at a CAGR of 5.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Anti-diabetic Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Care Drugs include Novo Nordisk, Sanofi, Eli Lilly, Biocon, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Mylan and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Care Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Care Drugs Market Segment Percentages, by Type, 2021 (%)

• Oral Anti-diabetic Drugs
• Insulins
• Non-insulin Injectable Drugs
• Other

Global Diabetes Care Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetes Care Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Medical Research Institute
• Clinic
• Other

Global Diabetes Care Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetes Care Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetes Care Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetes Care Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Sanofi
• Eli Lilly
• Biocon
• AstraZeneca
• Bristol Myers Squibb
• Boehringer Ingelheim
• Mylan
• Pfizer
• Johnson & Johnson
• Merck
• Novartis
• Astellas
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetes Care Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetes Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETES CARE DRUGS OVERALL MARKET SIZE

2.1 Global Diabetes Care Drugs Market Size: 2021 VS 2028
2.2 Global Diabetes Care Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetes Care Drugs Players in Global Market
3.2 Top Global Diabetes Care Drugs Companies Ranked by Revenue
3.3 Global Diabetes Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Care Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetes Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Care Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Diabetes Care Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetes Care Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetes Care Drugs Market Size Markets, 2021 & 2028
  4.1.2 Oral Anti-diabetic Drugs
  4.1.3 Insulins
  4.1.4 Non-insulin Injectable Drugs
  4.1.5 Other
4.2 By Type - Global Diabetes Care Drugs Revenue & Forecasts
  4.2.1 By Type - Global Diabetes Care Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Diabetes Care Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Diabetes Care Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetes Care Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Medical Research Institute
  5.1.4 Clinic
  5.1.5 Other
5.2 By Application - Global Diabetes Care Drugs Revenue & Forecasts
  5.2.1 By Application - Global Diabetes Care Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Diabetes Care Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Diabetes Care Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetes Care Drugs Market Size, 2021 & 2028
6.2 By Region - Global Diabetes Care Drugs Revenue & Forecasts
  6.2.1 By Region - Global Diabetes Care Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Diabetes Care Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetes Care Drugs Revenue, 2017-2028
  6.3.2 US Diabetes Care Drugs Market Size, 2017-2028
  6.3.3 Canada Diabetes Care Drugs Market Size, 2017-2028
  6.3.4 Mexico Diabetes Care Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetes Care Drugs Revenue, 2017-2028
  6.4.2 Germany Diabetes Care Drugs Market Size, 2017-2028
  6.4.3 France Diabetes Care Drugs Market Size, 2017-2028
  6.4.4 U.K. Diabetes Care Drugs Market Size, 2017-2028
  6.4.5 Italy Diabetes Care Drugs Market Size, 2017-2028
  6.4.6 Russia Diabetes Care Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetes Care Drugs Market Size, 2017-2028
  6.4.8 Benelux Diabetes Care Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetes Care Drugs Revenue, 2017-2028
  6.5.2 China Diabetes Care Drugs Market Size, 2017-2028
  6.5.3 Japan Diabetes Care Drugs Market Size, 2017-2028
  6.5.4 South Korea Diabetes Care Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetes Care Drugs Market Size, 2017-2028
  6.5.6 India Diabetes Care Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetes Care Drugs Revenue, 2017-2028
  6.6.2 Brazil Diabetes Care Drugs Market Size, 2017-2028
  6.6.3 Argentina Diabetes Care Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetes Care Drugs Revenue, 2017-2028
  6.7.2 Turkey Diabetes Care Drugs Market Size, 2017-2028
  6.7.3 Israel Diabetes Care Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetes Care Drugs Market Size, 2017-2028
  6.7.5 UAE Diabetes Care Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novo Nordisk
  7.1.1 Novo Nordisk Corporate Summary
  7.1.2 Novo Nordisk Business Overview
  7.1.3 Novo Nordisk Diabetes Care Drugs Major Product Offerings
  7.1.4 Novo Nordisk Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.1.5 Novo Nordisk Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Diabetes Care Drugs Major Product Offerings
  7.2.4 Sanofi Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Diabetes Care Drugs Major Product Offerings
  7.3.4 Eli Lilly Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Biocon
  7.4.1 Biocon Corporate Summary
  7.4.2 Biocon Business Overview
  7.4.3 Biocon Diabetes Care Drugs Major Product Offerings
  7.4.4 Biocon Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.4.5 Biocon Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Diabetes Care Drugs Major Product Offerings
  7.5.4 AstraZeneca Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Bristol Myers Squibb
  7.6.1 Bristol Myers Squibb Corporate Summary
  7.6.2 Bristol Myers Squibb Business Overview
  7.6.3 Bristol Myers Squibb Diabetes Care Drugs Major Product Offerings
  7.6.4 Bristol Myers Squibb Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.6.5 Bristol Myers Squibb Key News
7.7 Boehringer Ingelheim
  7.7.1 Boehringer Ingelheim Corporate Summary
  7.7.2 Boehringer Ingelheim Business Overview
  7.7.3 Boehringer Ingelheim Diabetes Care Drugs Major Product Offerings
  7.7.4 Boehringer Ingelheim Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.7.5 Boehringer Ingelheim Key News
7.8 Mylan
  7.8.1 Mylan Corporate Summary
  7.8.2 Mylan Business Overview
  7.8.3 Mylan Diabetes Care Drugs Major Product Offerings
  7.8.4 Mylan Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.8.5 Mylan Key News
7.9 Pfizer
  7.9.1 Pfizer Corporate Summary
  7.9.2 Pfizer Business Overview
  7.9.3 Pfizer Diabetes Care Drugs Major Product Offerings
  7.9.4 Pfizer Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Key News
7.10 Johnson & Johnson
  7.10.1 Johnson & Johnson Corporate Summary
  7.10.2 Johnson & Johnson Business Overview
  7.10.3 Johnson & Johnson Diabetes Care Drugs Major Product Offerings
  7.10.4 Johnson & Johnson Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.10.5 Johnson & Johnson Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Diabetes Care Drugs Major Product Offerings
  7.11.4 Merck Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News
7.12 Novartis
  7.12.1 Novartis Corporate Summary
  7.12.2 Novartis Business Overview
  7.12.3 Novartis Diabetes Care Drugs Major Product Offerings
  7.12.4 Novartis Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.12.5 Novartis Key News
7.13 Astellas
  7.13.1 Astellas Corporate Summary
  7.13.2 Astellas Business Overview
  7.13.3 Astellas Diabetes Care Drugs Major Product Offerings
  7.13.4 Astellas Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.13.5 Astellas Key News
7.14 Teva
  7.14.1 Teva Corporate Summary
  7.14.2 Teva Business Overview
  7.14.3 Teva Diabetes Care Drugs Major Product Offerings
  7.14.4 Teva Diabetes Care Drugs Revenue in Global Market (2017-2022)
  7.14.5 Teva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetes Care Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetes Care Drugs Market Drivers in Global Market
Table 3. Diabetes Care Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetes Care Drugs in Global Market
Table 5. Top Diabetes Care Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetes Care Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetes Care Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetes Care Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Care Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Care Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetes Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetes Care Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetes Care Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetes Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetes Care Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetes Care Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetes Care Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetes Care Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetes Care Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetes Care Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetes Care Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetes Care Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetes Care Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetes Care Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetes Care Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetes Care Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetes Care Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetes Care Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetes Care Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Novo Nordisk Corporate Summary
Table 31. Novo Nordisk Diabetes Care Drugs Product Offerings
Table 32. Novo Nordisk Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Diabetes Care Drugs Product Offerings
Table 35. Sanofi Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Diabetes Care Drugs Product Offerings
Table 38. Eli Lilly Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Biocon Corporate Summary
Table 40. Biocon Diabetes Care Drugs Product Offerings
Table 41. Biocon Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca Corporate Summary
Table 43. AstraZeneca Diabetes Care Drugs Product Offerings
Table 44. AstraZeneca Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Bristol Myers Squibb Corporate Summary
Table 46. Bristol Myers Squibb Diabetes Care Drugs Product Offerings
Table 47. Bristol Myers Squibb Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Boehringer Ingelheim Corporate Summary
Table 49. Boehringer Ingelheim Diabetes Care Drugs Product Offerings
Table 50. Boehringer Ingelheim Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Mylan Corporate Summary
Table 52. Mylan Diabetes Care Drugs Product Offerings
Table 53. Mylan Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Diabetes Care Drugs Product Offerings
Table 56. Pfizer Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Johnson & Johnson Corporate Summary
Table 58. Johnson & Johnson Diabetes Care Drugs Product Offerings
Table 59. Johnson & Johnson Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Diabetes Care Drugs Product Offerings
Table 62. Merck Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Novartis Corporate Summary
Table 64. Novartis Diabetes Care Drugs Product Offerings
Table 65. Novartis Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Astellas Corporate Summary
Table 67. Astellas Diabetes Care Drugs Product Offerings
Table 68. Astellas Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)
Table 69. Teva Corporate Summary
Table 70. Teva Diabetes Care Drugs Product Offerings
Table 71. Teva Diabetes Care Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetes Care Drugs Segment by Type in 2021
Figure 2. Diabetes Care Drugs Segment by Application in 2021
Figure 3. Global Diabetes Care Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetes Care Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetes Care Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Care Drugs Revenue in 2021
Figure 8. By Type - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 12. US Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 24. China Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetes Care Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetes Care Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Novo Nordisk Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biocon Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol Myers Squibb Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boehringer Ingelheim Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Mylan Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Johnson & Johnson Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Novartis Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Astellas Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Teva Diabetes Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)